WEBULL
News
ALUR
1.470
-2.00%
-0.030
Allurion Shareholders Approve Governance Changes and Capital Actions
TipRanks · 4h ago
Weekly Report: what happened at ALUR last week (1208-1212)?
Weekly Report · 4d ago
Tracking Saudi Sovereign Wealth Fund's 13F Portfolio - Q3 2025 Update
Seeking Alpha · 12/11 01:13
Weekly Report: what happened at ALUR last week (1201-1205)?
Weekly Report · 12/08 10:23
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 12/03 12:05
12 Consumer Discretionary Stocks Moving In Monday's After-Market Session
Benzinga · 12/01 21:06
Weekly Report: what happened at ALUR last week (1124-1128)?
Weekly Report · 12/01 10:18
Allurion reports initial results on Allurion Program, tirzepatide combination
TipRanks · 11/25 14:35
Allurion Technologies Reports Initial Results On Combination Of Allurion Program With Low-Dose Tirzepatide Therapy To Optimize Muscle Mass And GLP-1 Adherence
Benzinga · 11/25 14:28
Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence
Barchart · 11/25 08:25
12 Consumer Discretionary Stocks Moving In Monday's Intraday Session
Benzinga · 11/24 17:05
Weekly Report: what happened at ALUR last week (1117-1121)?
Weekly Report · 11/24 10:23
Allurion Smart Capsule Combined With Lifestyle Intervention Achieves 20% Average Weight Loss In 36 Weeks, Outperforming Lifestyle Intervention Alone, Study In 'Obesity Surgery' Shows
Benzinga · 11/20 14:08
Allurion Technologies Price Target Maintained With a $2.50/Share by Chardan Capital
Dow Jones · 11/20 12:35
Allurion Technologies Is Maintained at Neutral by Chardan Capital
Dow Jones · 11/20 12:35
Chardan Capital Maintains Neutral on Allurion Technologies, Maintains $2.5 Price Target
Benzinga · 11/20 12:25
Allurion partners with ProSurg to pioneer new weight loss approach in Brazil
TipRanks · 11/18 14:43
Allurion Technologies Announces Strategic Distribution Partnership With ProSurg Medical To Establish New Standard Of Care Focused On Metabolically Healthy Weight Loss
Benzinga · 11/18 14:09
Zacks Industry Outlook Highlights Boston Scientific, Insulet, BioLife Solutions and Allurion
NASDAQ · 11/18 09:01
Allurion Technologies Delays Q3 2025 Report Filing
TipRanks · 11/17 22:27
More
Webull provides a variety of real-time ALUR stock news. You can receive the latest news about ALLURION TECHNOLOGIES INC through multiple platforms. This information may help you make smarter investment decisions.
About ALUR
Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.